Haoting Zhan

537 total citations
38 papers, 300 citations indexed

About

Haoting Zhan is a scholar working on Rheumatology, Ophthalmology and Infectious Diseases. According to data from OpenAlex, Haoting Zhan has authored 38 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 10 papers in Ophthalmology and 9 papers in Infectious Diseases. Recurrent topics in Haoting Zhan's work include Ocular Diseases and Behçet’s Syndrome (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and COVID-19 Clinical Research Studies (6 papers). Haoting Zhan is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and COVID-19 Clinical Research Studies (6 papers). Haoting Zhan collaborates with scholars based in China and United States. Haoting Zhan's co-authors include Yongzhe Li, Linlin Cheng, Haolong Li, Songxin Yan, Chenxi Liu, Haizhen Chen, Yongmei Liu, Xiaomeng Li, Li Wang and Wenjie Zheng and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Trends in Immunology.

In The Last Decade

Haoting Zhan

35 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haoting Zhan China 9 90 75 59 52 37 38 300
Ana Belén Moreno‐Castaño Spain 12 65 0.7× 73 1.0× 31 0.5× 26 0.5× 25 0.7× 27 315
Shaozhe Cai China 11 91 1.0× 53 0.7× 117 2.0× 70 1.3× 19 0.5× 28 329
Georges El Hasbani Lebanon 11 52 0.6× 85 1.1× 113 1.9× 27 0.5× 51 1.4× 60 343
C. Bélizna France 8 52 0.6× 40 0.5× 155 2.6× 25 0.5× 53 1.4× 16 343
Jyoti Balani United States 9 117 1.3× 46 0.6× 17 0.3× 33 0.6× 58 1.6× 16 352
M. Le Besnerais France 11 24 0.3× 42 0.6× 89 1.5× 20 0.4× 53 1.4× 23 290
Andrea Duminuco Italy 11 29 0.3× 78 1.0× 26 0.4× 30 0.6× 31 0.8× 60 344
Paul Legendre France 10 39 0.4× 30 0.4× 68 1.2× 86 1.7× 100 2.7× 29 314
Doo‐Ho Lim South Korea 12 41 0.5× 44 0.6× 123 2.1× 46 0.9× 55 1.5× 46 292
Arvind Bhake India 10 32 0.4× 48 0.6× 25 0.4× 55 1.1× 39 1.1× 71 310

Countries citing papers authored by Haoting Zhan

Since Specialization
Citations

This map shows the geographic impact of Haoting Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoting Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoting Zhan more than expected).

Fields of papers citing papers by Haoting Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoting Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoting Zhan. The network helps show where Haoting Zhan may publish in the future.

Co-authorship network of co-authors of Haoting Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Haoting Zhan. A scholar is included among the top collaborators of Haoting Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoting Zhan. Haoting Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Z., Haoting Zhan, Jingdi Zhang, et al.. (2025). New biomarkers in IgA nephropathy. Clinical Immunology. 274. 110468–110468. 1 indexed citations
2.
Zhao, Mengzhu, Lei Zhang, Jing Luo, et al.. (2025). Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis. Annals of the Rheumatic Diseases. 84(12). 2075–2087. 1 indexed citations
3.
4.
Zhan, Haoting, Linlin Cheng, & Yongzhe Li. (2025). Neuro-Behçet’s disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis. Clinical & Experimental Immunology. 219(1). 3 indexed citations
5.
Zhan, Haoting, et al.. (2025). Evaluation of inflammatory-thrombosis panel as a diagnostic tool for vascular Behçet’s disease. Clinical Rheumatology. 44(3). 1279–1291. 1 indexed citations
6.
Liu, Yongmei, Haoting Zhan, Wei Feng, et al.. (2024). Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China. Frontiers in Medicine. 11. 1511227–1511227. 1 indexed citations
7.
Zhang, Jingdi, Linlin Cheng, Haolong Li, et al.. (2024). Immune cells and related cytokines in dilated cardiomyopathy. Biomedicine & Pharmacotherapy. 171. 116159–116159. 9 indexed citations
8.
Cheng, Linlin, Haoting Zhan, Yongmei Liu, et al.. (2023). Infectious agents and pathogenesis of Behçet's disease: An extensive review. Clinical Immunology. 251. 109631–109631. 5 indexed citations
9.
Cheng, Linlin, et al.. (2023). Bibliometric analysis of the global publication activity in the field of relapsing polychondritis during 1960–2023. Clinical Rheumatology. 42(12). 3201–3212. 5 indexed citations
10.
Cheng, Linlin, Mengzhu Zhao, Haoting Zhan, et al.. (2023). Development and validation of diagnostic and activity-assessing models for relapsing polychondritis based on laboratory parameters. Frontiers in Immunology. 14. 1274677–1274677. 5 indexed citations
11.
Xu, Yali, Linrong Li, Haolong Li, et al.. (2023). COVID-19 vaccination status, side effects, and perceptions among breast cancer survivors: a cross-sectional study in China. Frontiers in Public Health. 11. 1119163–1119163. 1 indexed citations
12.
Zhan, Haoting, Linlin Cheng, Haolong Li, et al.. (2023). Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet’s disease by leveraging gene microarray data. Immunologic Research. 71(6). 860–872. 2 indexed citations
13.
Cheng, Linlin, et al.. (2023). Progress and challenges in the use of blood biomarkers in relapsing polychondritis. Clinical & Experimental Immunology. 212(3). 199–211. 7 indexed citations
14.
Yi, Jie, Jingjing Song, Lijun Du, et al.. (2023). Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR. Annals of Clinical Microbiology and Antimicrobials. 22(1). 102–102. 4 indexed citations
15.
Zhan, Haoting, Yongliang Chen, Haolong Li, et al.. (2023). SARS-CoV-2 Vaccine Uptake among Patients with Chronic Liver Disease: A Cross-Sectional Analysis in Hebei Province, China. Vaccines. 11(8). 1293–1293. 1 indexed citations
16.
Cheng, Linlin, et al.. (2023). Chemokines and chemokine receptors in Behçet’s disease. Frontiers in Immunology. 14. 1109147–1109147. 2 indexed citations
17.
Zhan, Haoting, Huixia Gao, Yongmei Liu, et al.. (2022). Booster shot of inactivated SARS‐CoV‐2 vaccine induces potent immune responses in people living with HIV. Journal of Medical Virology. 95(1). e28428–e28428. 20 indexed citations
18.
Liu, Yongmei, Songxin Yan, Liubing Li, et al.. (2022). Circulating VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ as biomarkers of cancer in cancer-associated anti-TIF1-γ antibody-positive dermatomyositis. Clinical Rheumatology. 42(3). 817–830. 8 indexed citations
19.
Chen, Si, et al.. (2022). Identification of novel genes in Behcet’s disease using integrated bioinformatic analysis. Immunologic Research. 70(4). 461–468. 6 indexed citations
20.
Zhan, Haoting, Haolong Li, Chenxi Liu, et al.. (2021). Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 12. 674343–674343. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Belén Moreno‐Castaño Breakdown of academic impact, for papers by Shaozhe Cai Breakdown of academic impact, for papers by Georges El Hasbani Breakdown of academic impact, for papers by C. Bélizna Breakdown of academic impact, for papers by Jyoti Balani Breakdown of academic impact, for papers by M. Le Besnerais Breakdown of academic impact, for papers by Andrea Duminuco Breakdown of academic impact, for papers by Paul Legendre Breakdown of academic impact, for papers by Doo‐Ho Lim Breakdown of academic impact, for papers by Arvind Bhake
Rankless by CCL
2026